Edition:
United Kingdom

BioLife Solutions Inc (BLFS.OQ)

BLFS.OQ on NASDAQ Stock Exchange Capital Market

5.64USD
8:59pm GMT
Change (% chg)

$0.21 (+3.87%)
Prev Close
$5.43
Open
$5.44
Day's High
$5.65
Day's Low
$5.44
Volume
7,980
Avg. Vol
38,108
52-wk High
$7.53
52-wk Low
$1.52

Latest Key Developments (Source: Significant Developments)

Biolife Solutions Executes Supply Agreement With Iovance Biotherapeutics
11:30am GMT 

Dec 13 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS EXECUTES SUPPLY AGREEMENT WITH IOVANCE BIOTHERAPEUTICS.BIOLIFE SOLUTIONS - EXECUTED AGREEMENT TO SUPPLY CRYOSTOR CELL FREEZE MEDIA AND HYPOTHERMOSOL STORAGE AND SHIPPING MEDIA TO IOVANCE BIOTHERAPEUTICS.  Full Article

BioLife Solutions posts Q3 loss per share $0.03
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - BioLife Solutions Inc :Biolife Solutions announces third quarter 2017 financial results.Q3 loss per share $0.03.Biolife Solutions Inc - ‍gross margin for Q3 of 2017 was 63 pct compared with 57 pct in Q3 of 2016​.Biolife Solutions Inc - ‍2017 revenue is expected to range between $10.8 million to $11 million​.Biolife Solutions Inc - ‍2017 gross margin is expected to be between 60 pct and 62 pct​.Biolife Solutions Inc - qtrly ‍revenue $2.96 million versus $2.1 million.  Full Article

Biolife Solutions Q2 loss per share $0.06
Thursday, 10 Aug 2017 

Aug 10 (Reuters) - Biolife Solutions Inc ::Biolife solutions announces second quarter 2017 financial results.Expects FY 2017 revenue in excess of $10 million.Q2 loss per share $0.06.Biolife Solutions Inc says reaffirms full-year revenue guidance for biopreservation media products.  Full Article

BioLife Solutions qtrly product sales $1.99 mln
Thursday, 11 Aug 2016 

BioLife Solutions Inc : Q2 revenue rose 33 percent . BioLife Solutions reports results for second quarter 2016 . Sees FY 2016 revenue more than $8.0 million . Qtrly basic and diluted net loss per common share attributable to BioLife Solutions, Inc. $0.11 .Qtrly product sales $1.99 million versus $1.5 million a year ago.  Full Article

Biolife solutions executes 10 year supply agreement with Bellicum Pharmaceuticals for CryoStor use in cellular immunotherapies
Wednesday, 10 Aug 2016 

BioLife Solutions Inc :Biolife solutions executes 10 year supply agreement with Bellicum Pharmaceuticals for CryoStor® use in cellular immunotherapies.  Full Article

Biolife Solutions says entered into 10-year supply agreement with Kite Pharma
Monday, 11 Jul 2016 

Biolife Solutions Inc : Biolife solutions executes 10 year supply agreement with kite pharma for Cryostor use in CAR T cell therapies . Agreement provides for Kite's supply of Biolife's Cryostor clinical grade freeze media for cells and tissues .Says entered into a ten year supply agreement with Kite Pharma.  Full Article

Biolife Solutions and MNX Global Logistics partner to support immunocellular therapeutics
Thursday, 19 May 2016 

Biolife Solutions Inc : Company And MNX Global Logistics Partner to support immunocellular therapeutics with Cold Chain Logistics in ICT-107 Phase 3 clinical trial in glioblastoma .To use biologistex evo smart shipper and biologistex cold chain saas to offer logistics service for shipping apheresis starting material.  Full Article

Biolife Solutions Q1 loss per share $0.10
Thursday, 12 May 2016 

Biolife Solutions Inc : Qtrly loss per share $0.10 . Qtrly product revenue $1.9 million versus versus $1.5 million . Biolife solutions reports first quarter 2016 results .Sees fy 2016 revenue more than $8.0 million.  Full Article

BioLife Solutions Inc names Roderick de Greef Chief Financial Officer & Secretary
Wednesday, 4 May 2016 

BioLife Solutions Inc:Says Roderick de Greef has transitioned from Interim Chief Financial Officer and Secretary to full time employment and is relocating to the Seattle area.  Full Article

BioLife Solutions, Inc announces CFO change
Monday, 7 Mar 2016 

BioLife Solutions, Inc:Names Roderick De Greef interim Chief Financial Officer.  Full Article